Elanco

Elanco is a global animal health company that develops, manufactures, and markets products and services to prevent and treat diseases in farm animals and pets. The company was formerly a subsidiary of Eli Lilly and Company before becoming fully independent in 2019. While its primary role is an operating company, Elanco also engages in strategic investments, such as co-founding BiomEdit by contributing intellectual property and assets in exchange for equity.